CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Ramipril

雷米普利 杂质对照品Ramipril Impurities

EP34 个杂质条目34 impurity entries

本页汇总 雷米普利 的 34 个杂质对照品条目,其中药典杂质标注了 EP/USP 编号。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 34 impurity reference standards of Ramipril with EP/USP numbering where applicable. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 雷米普利(Ramipril)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a liquid chromatographic method for the determination of the related substances of ramipril in Altace capsules
    Journal of pharmaceutical and biomedical analysis · 2000 · Hogan BL et al.  ·  PMID 10975240  ·  DOI
  2. 杂质研究Impurity studiesDevelopment and validation of an rp-hplc method for simultaneous determination of Ramipril and Amlodipine in tablets
    Journal of pharmaceutical analysis · 2013 · Dai SY et al.  ·  PMID 29403852  ·  DOI
  3. 杂质研究Impurity studiesStability-indicating Reversed-phase Liquid Chromatographic Method for Simultaneous Determination of Losartan Potassium and Ramipril in Tablets
    Indian journal of pharmaceutical sciences · 2012 · Kollipara S et al.  ·  PMID 23440900  ·  DOI
  4. 分析方法Analytical MethodsThe development and validation of a quality by design based process analytical tool for the inline quantification of Ramipril during hot-melt extrusion
    International journal of pharmaceutics · 2020 · Dadou SM et al.  ·  PMID 32360547  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of bioanalytical method for simultaneous estimation of ramipril and hydrochlorothiazide in human plasma using liquid chromatography-tandem mass spectrometry
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2014 · Patel JR et al.  ·  PMID 25240204  ·  DOI

雷米普利 —— 原料药与杂质对照品Ramipril — drug substance & impurities

共 35 个条目(含原料药本体)35 items incl. the drug substance
Ramipril structure
EP原料药 APIAPI
雷米普利Ramipril
Ramipril
CAS No.87333-19-5
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 5(Ramipril EP Impurity A) structure
EPA
雷米普利杂质5(雷米普利EP杂质A)Ramipril Impurity 5(Ramipril EP Impurity A)
Ramipril Impurity 5(Ramipril EP Impurity A)
CAS No.108313-11-7
Chemical FormulaC22H30N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 11(Ramipril EP Impurity B) structure
EPB
雷米普利杂质11(雷米普利EP杂质B)Ramipril Impurity 11(Ramipril EP Impurity B)
Ramipril Impurity 11(Ramipril EP Impurity B)
CAS No.295328-72-2
Chemical FormulaC24H34N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 3 Hydrochloride(Ramipril EP Impurity C Hydrochloride) structure
EPC
雷米普利杂质3 盐酸盐 (雷米普利EP杂质C 盐酸盐)Ramipril Impurity 3 Hydrochloride(Ramipril EP Impurity C Hydrochloride)
Ramipril Impurity 3 Hydrochloride(Ramipril EP Impurity C Hydrochloride)
CAS No.885516-61-0
Chemical FormulaC23H38N2O5·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 3 Monomer(Ramipril EP Impurity C Monomer) structure
EPC
雷米普利杂质3 单体 (雷米普利EP杂质C 单体)Ramipril Impurity 3 Monomer(Ramipril EP Impurity C Monomer)
Ramipril Impurity 3 Monomer(Ramipril EP Impurity C Monomer)
CAS No.99742-35-5
Chemical FormulaC23H38N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 4(Ramipril EP Impurity D) structure
EPD
雷米普利杂质4(雷米普利EP杂质D)Ramipril Impurity 4(Ramipril EP Impurity D)
Ramipril Impurity 4(Ramipril EP Impurity D)
CAS No.108731-95-9
Chemical FormulaC23H30N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 1  (Ramipril EP Impurity E) structure
EPE
雷米普利杂质1 (雷米普利EP杂质E)Ramipril Impurity 1 (Ramipril EP Impurity E)
Ramipril Impurity 1 (Ramipril EP Impurity E)
CAS No.87269-97-4
Chemical FormulaC21H28N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 8(Ramipril EP Impurity H) structure
EPH
雷米普利杂质8(雷米普利EP杂质H)Ramipril Impurity 8(Ramipril EP Impurity H)
Ramipril Impurity 8(Ramipril EP Impurity H)
CAS No.104195-90-6
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 9 (Ramipril EP Impurity I) structure
EPI
雷米普利杂质9 (雷米普利EP杂质I)Ramipril Impurity 9 (Ramipril EP Impurity I)
Ramipril Impurity 9 (Ramipril EP Impurity I)
CAS No.129939-65-7
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 10(Ramipril EP Impurity J) structure
EPJ
雷米普利杂质10(雷米普利EP杂质J)Ramipril Impurity 10(Ramipril EP Impurity J)
Ramipril Impurity 10(Ramipril EP Impurity J)
CAS No.1246253-05-3
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 2 (Ramipril  EP Impurity K) structure
EPK
雷米普利杂质2(雷米普利EP杂质K)Ramipril Impurity 2 (Ramipril EP Impurity K)
Ramipril Impurity 2 (Ramipril EP Impurity K)
CAS No.108736-10-3
Chemical FormulaC21H26N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 12(Ramipril EP Impurity L) structure
EPL
雷米普利杂质12(雷米普利EP杂质L)Ramipril Impurity 12(Ramipril EP Impurity L)
Ramipril Impurity 12(Ramipril EP Impurity L)
CAS No.1309040-96-7
Chemical FormulaC23H30N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 14(Ramipril EP Impurity N) structure
EPN
雷米普利杂质14(雷米普利EP杂质N)Ramipril Impurity 14(Ramipril EP Impurity N)
Ramipril Impurity 14(Ramipril EP Impurity N)
CAS No.129939-63-5
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 16 structure
16
雷米普利杂质16Ramipril Impurity 16
Ramipril Impurity 16
CAS No.93779-29-4
Chemical FormulaC15H19NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 17 structure
17
雷米普利杂质17Ramipril Impurity 17
Ramipril Impurity 17
CAS No.111955-48-7
Chemical FormulaC18H14O8
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 18 structure
18
雷米普利杂质18Ramipril Impurity 18
Ramipril Impurity 18
CAS No.87172-82-5
Chemical FormulaC11H10O7
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 20 structure
20
雷米普利杂质20Ramipril Impurity 20
Ramipril Impurity 20
CAS No.65582-57-2
Chemical FormulaC11H10O7
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 21 structure
21
雷米普利杂质21Ramipril Impurity 21
Ramipril Impurity 21
CAS No.753405-33-3
Chemical FormulaC23H32N2O5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 25 structure
25
雷米普利杂质25Ramipril Impurity 25
Ramipril Impurity 25
CAS No.1207512-32-0
Chemical FormulaC19H16O8
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 26 structure
26
雷米普利杂质26Ramipril Impurity 26
Ramipril Impurity 26
CAS No.84324-12-9
Chemical FormulaC15H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 27 structure
27
雷米普利杂质27Ramipril Impurity 27
Ramipril Impurity 27
CAS No.85196-26-5
Chemical FormulaC15H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 28 structure
28
雷米普利杂质28Ramipril Impurity 28
Ramipril Impurity 28
CAS No.122076-80-6
Chemical FormulaC15H21NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 29 structure
29
雷米普利杂质29Ramipril Impurity 29
Ramipril Impurity 29
CAS No.84023-58-5
Chemical FormulaC13H17NO4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 30 structure
30
雷米普利杂质30Ramipril Impurity 30
Ramipril Impurity 30
CAS No.129101-19-5
Chemical FormulaC15H19NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 31 structure
31
雷米普利杂质31Ramipril Impurity 31
Ramipril Impurity 31
CAS No.1342316-08-8
Chemical FormulaC16H18ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 32 (N-Nitroso Ramipril) structure
32
雷米普利杂质32 (N-亚硝基雷米普利)Ramipril Impurity 32 (N-Nitroso Ramipril)
Ramipril Impurity 32 (N-Nitroso Ramipril)
CAS No.3028194-80-8
Chemical FormulaC23H31N3O6
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 34 structure
34
雷米普利杂质34Ramipril Impurity 34
Ramipril Impurity 34
CAS No.22333-70-6
Chemical FormulaC18H14O8
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 35 structure
35
雷米普利杂质35Ramipril Impurity 35
Ramipril Impurity 35
CAS No.1121585-20-3
Chemical FormulaC19H16O8
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 36 structure
36
雷米普利杂质36Ramipril Impurity 36
Ramipril Impurity 36
CAS No.243658-52-8
Chemical FormulaC12H14O4
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 37 structure
37
雷米普利杂质37Ramipril Impurity 37
Ramipril Impurity 37
CAS No.20908-27-4
Chemical FormulaC12H12O3
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 38 structure
38
雷米普利杂质38Ramipril Impurity 38
Ramipril Impurity 38
CAS No.105167-27-9
Chemical FormulaC15H19NO5
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 39 structure
39
雷米普利杂质39Ramipril Impurity 39
Ramipril Impurity 39
CAS No.109428-53-7
Chemical FormulaC8H13NO2
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 39 Hydrochloride structure
39
雷米普利杂质39 盐酸盐Ramipril Impurity 39 Hydrochloride
Ramipril Impurity 39 Hydrochloride
CAS No.87269-86-1
Chemical FormulaC8H13NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 40 Hydrochloride structure
40
雷米普利杂质40 盐酸盐Ramipril Impurity 40 Hydrochloride
Ramipril Impurity 40 Hydrochloride
CAS No.1342316-10-2
Chemical FormulaC8H11NO2·HCl
Purity>95%询价On request
10mg25mg50mg100mg
Ramipril Impurity 40 structure
40
雷米普利杂质40Ramipril Impurity 40
Ramipril Impurity 40
CAS No.1342948-62-2
Chemical FormulaC8H11NO2
Purity>95%询价On request
10mg25mg50mg100mg
本品种含亚硝胺类杂质条目。亚硝胺杂质属于 ICH M7 关注的潜在致突变杂质,建议在方法开发中纳入专属性考察。This list includes nitrosamine entries. Nitrosamines are potential mutagenic impurities under ICH M7 and should be covered by a specific method.

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

雷米普利 —— 研究文献与合成路线Ramipril — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 雷米普利 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Ramipril. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. Cardiac arrhythmias are ameliorated by local inhibition of angiotensin formation and bradykinin degradation with the converting-enzyme inhibitor ramipril
    Linz W, Schölkens BA, Kaiser J, et al. · Cardiovascular drugs and therapy · 1989 · 被引 23cited 23
  2. Development of a capillary electrophoresis method for the assay of ramipril and its impurities: an issue of cis-trans isomerization
    Orlandini S, Gotti R, Giannini I, et al. · Journal of chromatography. A · 2011 · 被引 14cited 14
  3. Smart UV spectrophotometric methods based on simple mathematical filtration for the simultaneous determination of celecoxib and ramipril in their pharmaceutical mixtures with amlodipine: A comparative statistical study
    Attala K, Elsonbaty A · Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy · 2021 · 被引 19cited 19
  4. Kinetic spectrophotometric method for the determination of ramipril in pharmaceutical formulations
    Rahman N, Ahmad Y, Azmi SN · AAPS PharmSciTech · 2005 · 被引 6cited 6
  5. Square wave voltammetric determination of the angiotensin-converting enzyme inhibitors cilazapril, quinapril and ramipril in pharmaceutical formulations
    Prieto JA, Jiménez RM, Alonso RM · Farmaco (Societa chimica italiana : 1989) · 2003 · 被引 3cited 3

合成与制备工艺专利Synthesis & process patents

  1. A PROCESS FOR PREPARATION OF RAMIPRIL
    KUMAR ASHOK, SOUDAGAR SATISH RAJANIKANT, PANDA NALINAKSHYA BALARAM, GAWADE SANJAY PANDURANG, et al. · 公开号 WO2009122433WO2009122433 · 2009
  2. PROCESS FOR THE PREPARATION OF RAMIPRIL
    KOOH DAE HO, BAIK YOUNG CHAN, SHIN YONG BONG · 公开号 KR20100004315KR20100004315 · 2010
  3. METHOD FOR THE SYNTHESIS OF A RAMIPRIL INTERMEDIATE
    DE LANGE BEN, HEEMSKERK DENNIS · 公开号 US2011263871US2011263871 · 2011
  4. METHOD FOR THE SYNTHESIS OF A RAMIPRIL INTERMEDIATE
    LANGE DE BEN, HEEMSKERK DENNIS · 公开号 EP2344455EP2344455 · 2011
  5. METHOD FOR THE SYNTHESIS OF A RAMIPRIL INTERMEDIATE
    LANGE DE BEN, HEEMSKERK DENNIS · 公开号 WO2010049401WO2010049401 · 2010

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

雷米普利 杂质谱研究要点Ramipril — impurity profiling notes

下面这些是拿到 雷米普利 的 35 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 35 impurity entries for Ramipril, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

本品种含药典编号杂质(EP/USP)。申报时药典已收载的杂质通常需要逐项对照,建议优先备齐药典编号对照品,再补充工艺与降解杂质。This drug substance includes pharmacopoeially designated impurities (EP/USP). Monographed impurities normally need item-by-item comparison during filing, so secure the pharmacopoeial standards first, then fill in process and degradation impurities.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances